Is it safe to prescribe etoricoxib (a COX‑2 inhibitor) to a patient with hypertension?

Can Etoricoxib Be Given to Hypertensive Patients?

Etoricoxib can be prescribed to hypertensive patients, but only with significant caution: blood pressure must be well-controlled before initiation, monitored closely throughout therapy, and the lowest effective dose should be used for the shortest duration possible. 1, 2

Key Cardiovascular and Blood Pressure Risks

Blood Pressure Elevation

• Etoricoxib significantly raises blood pressure more than other NSAIDs. In the MEDAL study comparing etoricoxib to diclofenac, etoricoxib was associated with significantly increased systolic BP (p<0.0001), diastolic BP (p<0.0001 to p=0.0015), and higher odds of exceeding predefined blood pressure limits (p<0.0001 to p=0.002). 3

• A direct comparison study found etoricoxib raised systolic BP by a mean of 16.2±15 mmHg versus 8.5±11 mmHg with diclofenac (p=0.004), and diastolic BP by 7.1±9 mmHg versus 2.4±7 mmHg (p=0.004) in hypertensive patients. 4

• Meta-analysis data shows etoricoxib has a risk ratio of 1.52 (1.39-1.66, p=0.01) for developing hypertension compared to nonselective NSAIDs. 5

Cardiovascular Thrombotic Events

• All COX-2 inhibitors, including etoricoxib, carry increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. 1, 2

• The American Heart Association meta-analysis showed COX-2 inhibitors versus placebo had a rate ratio of 1.86 (1.33-2.59, p=0.0003) for myocardial infarction. 1

• Etoricoxib specifically showed 2 MI events per 753 person-years versus 0 per 414 person-years with placebo in pooled trial data. 1

Clinical Management Algorithm

Before Prescribing

• Ensure hypertension is well-controlled before initiating etoricoxib, as NSAIDs can lead to onset of new hypertension or worsening of pre-existing hypertension. 2

• Assess for additional cardiovascular risk factors: patients with known CV disease, recent bypass surgery, unstable angina, MI, or stroke have greater absolute risk increases. 1

• Consider alternative analgesics first: acetaminophen or aspirin at lowest efficacious doses should be tried before escalating to COX-2 inhibitors. 1

During Treatment

• Monitor blood pressure closely during initiation and throughout therapy. 2

• Monitor renal function, as NSAIDs can cause sodium retention and impaired renal perfusion, contributing to adverse cardiovascular effects. 1

• Use the lowest effective dose for the shortest duration necessary to control symptoms. 1, 2

Antihypertensive Medication Interactions

• Etoricoxib attenuates the effectiveness of multiple antihypertensive classes, including beta-blockers (atenolol), ACE inhibitors (ramipril), and angiotensin receptor blockers (telmisartan). 6

• Calcium channel blockers appear to maintain antihypertensive effects better than other drug classes when used concurrently with NSAIDs. 3

• NSAIDs may diminish the antihypertensive effect of ACE inhibitors and reduce the natriuretic effect of diuretics. 2

Critical Contraindications

• Absolutely contraindicated in patients with recent CABG surgery (first 10-14 days postoperatively), as COX-2 inhibitors showed increased incidence of MI and stroke in this population. 2

Important Caveats

• The excess cardiovascular risk is dose-dependent and duration-dependent, making short-term use at minimal doses preferable. 1

• History of hypertension was the strongest predictor of blood pressure changes (+3.04 mmHg for systolic, p<0.0001) in the MEDAL study, followed by age ≥65 years. 3

• Patients should be informed about signs/symptoms of serious CV events and instructed when to seek care, as these events can occur without warning. 2

• Fluid retention and edema have been observed with NSAIDs; use with particular caution in patients with heart failure. 2